http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2231228-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5e17cdb18905709242be1f81e6361854 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2037-0023 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2037-0061 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2005-1585 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2005-14208 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2037-0038 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2037-003 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-205 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M37-0015 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-14276 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-1723 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-00 |
| filingDate | 2008-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c19a8c162aa10c22516ddefb8254e1c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7e60331bf0c1d8913ab27a07c05ece8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9169a3660201dedb6660bf4d9a2f1a4d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b9163fcd1629a8eee5bd0e08081519f2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_061d407dce1d1b7ef4fae1d11f75d52e |
| publicationDate | 2010-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-2231228-A2 |
| titleOfInvention | Integrated intra-dermal delivery, diagnostic and communication system |
| abstract | In one embodiment, an IDDC system utilizes an intelligent therapeutic agent delivery system comprised of one, but more likely an array of 'cells' containing therapeutic agent(s) and/or diagnostic agents(s); an integrated bio-sensing system designed to sample and analyze biological materials using multiple sensors that include both hardware and software components. The software component involves biomedical signal processing to analyze complex liquid mixtures and a microcontroller(s) acts as interface to the biosensors, to the therapeutic delivery elements, and to a communications system(s) for the purpose of controlling the amount of therapeutic agent to deliver and also to provide information in a useful form to interested parties on the progress of therapy and compliance thereto. The synergistic effect of combining the above describe elements is expected to dramatically improve patient compliance with prescribed therapy, quality and timeliness of care provided by physicians, and at the same time reduce the cost of providing effective healthcare to IDDC system users, thereby improving profitability for Managed Care organizations and pharmaceutical companies utilizing the system. |
| priorityDate | 2007-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 383.